STOCK TITAN

KYMR (KYMR) Form 144 shows option exercise and 10b5-1 sales by insider

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

KYMR submitted a Form 144 notice disclosing the proposed sale and recent dispositions tied to an option exercise and 10b5-1 programs. The filing shows an exercise of stock options for 2,500 shares on 03/20/2026 for cash. It also lists prior 10b5-1 sales by Pamela Esposito: 2,500 shares on 02/20/2026 and 5,500 shares on 01/20/2026, with proceeds shown for each transaction.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does KYMR's Form 144 disclose about recent transactions?

The Form 144 discloses an option exercise of 2,500 shares on 03/20/2026 and 10b5-1 sales of 2,500 and 5,500 shares on 02/20/2026 and 01/20/2026, respectively. The filing lists cash proceeds for each sale.

Who executed the 10b5-1 sales listed in the KYMR Form 144?

The filing names Pamela Esposito as the 10b5-1 seller at an address in Watertown, MA. The record shows 10b5-1 dispositions on 01/20/2026 and 02/20/2026 with stated share counts and proceeds.

How many shares were exercised and by what method in the Form 144?

An exercise of stock options for 2,500 shares is recorded on 03/20/2026 and the method of payment is shown as cash in the filing. The entry is labeled as an issuer transaction.

What proceeds are reported for the listed transactions in KYMR's filing?

The filing shows proceeds associated with each sale: $218,270.00 for the 02/20/2026 sale and $373,521.20 for the 01/20/2026 sale. The exercise entry lists $198,925.00 alongside the 2,500-share exercise.

Does the Form 144 indicate whether the shares are being sold on an exchange?

The filing includes NASDAQ as the market identifier for the securities. The Form 144 entries list transaction dates and methods but do not specify execution venues beyond the exchange code shown.
Kymera Therapeutics, Inc.

NASDAQ:KYMR

View KYMR Stock Overview

KYMR Rankings

KYMR Latest News

KYMR Latest SEC Filings

KYMR Stock Data

6.50B
79.45M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
WATERTOWN